Not content with just providing the best possible care, our goal is to also find ways in delaying, or even preventing dementia.
In 2012, Anglicare collaborated with the KaRa Institute of Neurological Diseases (KaRa MINDS) on the KARVIAH clinical research study, the first of its kind to be conducted within a Retirement Village setting for people at an age most at risk. The study found that two important blood markers (fatty acids and ferritin) correlate with an elevated level of plaque in the brain, prior to the onset of dementia symptoms. These markers are not new. However, the correlation with the accumulating beta-amyloid protein, at a time when symptoms are not present, is highly significant.
Anglicare continues to invest into leading dementia research, providing assistance to the KARVIAH X-TND project that is being conducted by KaRa MINDS.
In addition to research investment, Anglicare provides support to people living with dementia and their carers through its Dementia Advisory Services. These services aim to provide information, education and support to improve the wellbeing of people living with dementia and those who care for them.
In our Residential Care Homes, a dedicated group of staff including researchers, clinicians, support staff, subject matter experts, lifestyle consultants, chaplains, managers and care workers, work together to identify important services ensuring residents and their families have a well-supported and seamless dementia care journey.
